Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.15
1.96
NAV
₹29.52
₹430.15
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1229.42 Cr
₹4063.64 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
1.19%
4.05%
3 Year
21.47%
24.17%
5 Year
13.08%
15.33%
Equity
99.69%
98.16%
Cash
0.31%
1.77%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.34% |
Abbott India Ltd. | 5.89% |
Divi's Laboratories Ltd. | 5.83% |
Healthcare Global Enterprises Ltd. | 5.39% |
Max Healthcare Institute Ltd. | 5.14% |
Cipla Ltd. | 5.10% |
Apollo Hospitals Enterprise Ltd. | 4.25% |
Rainbow Children's Medicare Ltd. | 4.23% |
Mankind Pharma Ltd. | 3.57% |
Bayer CropScience Ltd. | 3.51% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Divi's Laboratories Ltd. | 6.59% |
Acutaas Chemicals Ltd. | 5.67% |
Apollo Hospitals Enterprise Ltd. | 5.48% |
Max Healthcare Institute Ltd. | 4.97% |
Lupin Ltd. | 4.10% |
Aster DM Healthcare Ltd. | 3.96% |
Torrent Pharmaceuticals Ltd. | 3.74% |
Aether Industries Ltd. | 3.56% |
Biocon Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999
